The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma
- 29 May 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 33 (1) , 31-39
Abstract
Background and Objectives: Invasive micropapillary carcinoma (IMPC) of the breast is a rare and aggressive variant of invasive ductal carcinoma characterized by high-grade lymphovascular invasion and high rates of nodal metastasis. The prognostic significance of the micropapillary component (MC) ratio that constitutes this aggressive variation is controversial. In this study, we aimed to investigate the effect of the MC ratio on the prognosis of these patients. Methods: The data of 47 patients with IMPC were retrospectively reviewed. Patients were divided into two groups: MC ratio of 10–75% (Group 1) and greater than 75% (Group 2). The demographic characteristics of the patients, histopathologic features of the tumors, and survival rates were compared. Results: We detected no significant difference in demographic characteristics between groups 1 and 2 (p = 0.21). No significant difference was detected in terms of tumor diameter, lymph node metastasis, lymphovascular invasion, histologic grade, multicentricity, local recurrence, distant metastasis, and overall survival. Conclusion: In the micropapillary subgroup of invasive ductal carcinoma, although positive receptor characteristics are directly proportional to the increase in MC ratio, recurrence and survival rates are not affected by micropapillary component level.Keywords
This publication has 35 references indexed in Scilit:
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Invasive Ductal Carcinomas of the Breast Showing Partial Reversed Cell Polarity are Associated With Lymphatic Tumor Spread and may Represent Part of a Spectrum of Invasive Micropapillary CarcinomaAmerican Journal of Surgical Pathology, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Characteristic Morphology of Invasive Micropapillary Carcinoma of the Breast: An Immunohistochemical AnalysisJapanese Journal of Clinical Oncology, 2010
- Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary CarcinomaAmerican Journal of Surgical Pathology, 2009
- Breast Carcinoma With Micropapillary Features: Clinicopathologic Study and Long-Term Follow-Up of 100 CasesInternational Journal of Surgical Pathology, 2008
- Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast CancerJapanese Journal of Clinical Oncology, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Invasive Micropapillary Carcinoma of the BreastAmerican Journal of Clinical Pathology, 2006
- Invasive Micropapillary Carcinoma of the BreastAmerican Journal of Clinical Pathology, 2004